Welcome to the opening day of a week-long celebration of KMAland cross country. Today, we are bringing you KMAland Iowa ...

The Lilly Collection is now a part of the National Numismatic Collection. An act of Congress in 1968 brought the coins from Lilly’s estate to the Smithsonian. This acquisition included 1,227 U.S. gold ...

Brought to you by Eli LillyFeeling stagnant at work? Hungry for change? Craving something new? Your new career could ...

Fire chiefs in Columbia, Lebanon and Coventry reflected on what their line of duty means to them on National First Responders Day, which was celebrated Monday. Columbia Volunteer Fire Department Chief ...

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.30% this morning as a strong earnings report from Alphabet boosted sentiment, while investors awaited a fresh batch of U.S. economic data ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best BofA’s top growth stocks with the fastest projected EPS growth rates. For the ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. J&J evaluated its Tremfya in patients with low ...

Eli Lilly and Company Stock Down 1.3 % Eli Lilly and Company stock opened at $891.66 on Friday. The firm has a market cap of $847.44 billion, a P/E ratio of 131.32, a P/E/G ratio of 2.79 and a ...

BALTIMORE (WBFF) — On a Wednesday edition of FOX45 Morning News, Shannon Lilly spoke with Vice Chair with the Pride of Baltimore II Ann Costlow about, 'Sailabration: Sailing Traditions in Ink ...

Donanemab, manufactured by pharmaceutical giant Eli Lilly, is a targeted antibody drug which slows the early stages of Alzheimer’s. The drug, and another new drug for Alzheimer’s called ...

It provided little detail other than saying that Eli Lilly had shown it could “meet the present and projected national demand,” while acknowledging that patients could still see periodic ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily outperforming both the S&P 500 and Nasdaq Composite indexes. Much of the ...